| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000016501 |
| Receipt No. | R000019161 |
| Scientific Title | Laparoscopic radical hysterectomy |
| Date of disclosure of the study information | 2015/02/10 |
| Last modified on | 2022/08/17 (Ver. 8) |
| Basic information | ||
| Public title | Laparoscopic radical hysterectomy | |
| Acronym | Laparoscopic radical hysterectomy | |
| Scientific Title | Laparoscopic radical hysterectomy | |
| Scientific Title:Acronym | Laparoscopic radical hysterectomy | |
| Region |
|
|
| Condition | ||
| Condition | Cervical cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the feasibility, safety and oncological outcome of the laparoscopic radical hysterectomy |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Evaluation of resected specimen
3 yr disease free survival |
| Key secondary outcomes | Diesease free survival
3,5yr survival operation time blood loss transfuseon rate intra-postoperative complication post operative quality of life compared with the laparotomy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Historical |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | surgery
Laparoscopic radical hysterectomy & pelvic lymphadenectomy |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1) cervical cancer
stage IA2,IB1,IIA1 |
|||
| Key exclusion criteria | 1) huge leiomyoma or adenomayosis
2) severe comorbidity 3) performance status 3.4 4) patients judged inappropriate for this study by the physician |
|||
| Target sample size | 3 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Kansai Medical University | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 573-1010 | ||||||
| Address | 2-5-1 Shinmachi, Hirakata Osaka 573-1010 | ||||||
| TEL | 0728040101 | ||||||
| kitamas@hirakata.kmu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Kansai Medical University | ||||||
| Division name | Obstetrics and Gynecology | ||||||
| Zip code | 573-1010 | ||||||
| Address | 2-5-1 Shinmachi, Hirakata Osaka 573-1010 | ||||||
| TEL | 072-804-0101 | ||||||
| Homepage URL | |||||||
| kitamas@hirakata.kmu.ac.jp | |||||||
| Sponsor | |
| Institute | Kansai Medical University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kansai Medical University |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Kansai Medical University |
| Address | Shinmachi 2-5-1, HIrakata City, Osaka, Japan |
| Tel | 072-804-0101 |
| kitamas@hirakata.kmu.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 関西医科大学 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | none |
| Publication of results | Unpublished |
| Result | |||||||
| URL related to results and publications | none | ||||||
| Number of participants that the trial has enrolled | 3 | ||||||
| Results | no complications | ||||||
| Results date posted |
|
||||||
| Results Delayed | |||||||
| Results Delay Reason | |||||||
| Date of the first journal publication of results | |||||||
| Baseline Characteristics | not paricular | ||||||
| Participant flow | as scheduled | ||||||
| Adverse events | none | ||||||
| Outcome measures | no abnormal findings | ||||||
| Plan to share IPD | |||||||
| IPD sharing Plan description | |||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019161 |